• Mashup Score: 3
    The Definition and Overview of Treatment Options in nmCRPC Presentation - Howard Scher - 4 year(s) ago

    Howard Scher presents an overview of treatment options for non-metastatic castration-resistant prostate cancer, (nmCRPC), those patients who never had detectable metastases on “conventional/standard” imaging, which includes a radionuclide bone scan and CT abdomen/pelvis +/- and MRI. These patients are generally asymptomatic from cancer itself with some symptoms from prior therapies….

    Source: UroToday
    Categories: Urology
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Definition and overview of treatment options in #nmCRPC. Howard Scher, MD @sloan_kettering discusses patients who never had detectable metastases on “conventional/ standard” imaging @apccc19. #WatchNow on UroToday > https://t.co/sckYL1Z9fQ #APCCC19 https://t.co/l4HyttE016

  • Mashup Score: 6
    Expert advice: coronavirus guide for athletes - AW - 4 year(s) ago

    Dr Noel Pollock, chief medical officer at British Athletics, and co-authors Dr James Hull, Dr John Rogers, Dr Nathan Lewis and Dr James Brown offer guidance on physical activity, immune function and what to do if you get COVID-19

    Source: AW
    Categories: Rheumatology
    Tweet Tweets with this article
    • Profile photo of BJSM_BMJ
      BJSM_BMJ

      Some practical tips and advice for any athletes or fitness fanatics in the current climate #COVID-19 👏@DrNoelPollock @Breathe_to_win @jpmrogers @sportsdocjb https://t.co/Eix2Bcz47u

  • Mashup Score: 9
    COVID-19 Global Rheumatology Alliance discourages off-label use of hydroxychloroquine - 4 year(s) ago

    An international group of more than a dozen rheumatologists have cosigned an article published in Annals of Internal Medicine discouraging the off-label use of hydroxychloroquine for COVID-19, until said use is justified by data and the drug’s supply is replenished.“There is enough rationale to justify the continued investigation of the efficacy and safety of HCQ in hospitalized

    Source: www.healio.com
    Categories: Rheumatology
    Tweet Tweets with this article
    • Profile photo of HealioRheum
      HealioRheum

      An international group of more than a dozen rheumatologists, representing @rheum_covid, have cosigned an article discouraging the off-label use of #hydroxychloroquine for #COVID19, until said use is justified by data and the drug’s supply is replenished https://t.co/nGkKBAqMtf

  • Mashup Score: 8
    AUA Inside Tract Podcast - Episode 92 - American Urological Association - 4 year(s) ago

    More providers than ever are using telehealth services to continue seeing and treating patients during the COVID-19 pandemic. The federal government has taken a number of measures to ease the way for this transition, including issuing waivers for certain provisions of the Health Insurance Portability & Accountability Act (HIPAA). Alisa Chestler of Baker Donelson discusses what providers need to…

    Source: www.auanet.org
    Categories: Urology
    Tweet Tweets with this article
    • Profile photo of AmerUrological
      AmerUrological

      Today's podcast: COVID-19: Understanding HIPAA Relief Provisions for Telehealth with Alisa Chestler Listen now: https://t.co/nlkabeIzC1 https://t.co/5JSXyeJ3C3

  • Mashup Score: 0
    Penile traction device shows benefit in men post-radical prostatectomy - 4 year(s) ago

    Interim results from a clinical trial of a next-generation penile traction therapy device were encouraging and demonstrated statistically significant increases in penile length and a smaller reduction in erectile function among post-prostatectomy men who were treated with the device, known as RestoreX, according to PathRight Medical.

    Source: Urology Times
    Categories: Urology
    Tweet Tweets with this article
    • Profile photo of UrologyTimes
      UrologyTimes

      Penile traction device shows benefit in men post-radical prostatectomy https://t.co/veXClsylUE #urology

Load More